News

News

2.5% Injectable Polyacrylamide Hydrogel for Joint Health in Horses


Release time:

May 18,2024

In a new study researchers have shown 2.5% injectable polyacrylamide hydrogel (iPAAG) injected into the joints causes a beneficial type of inflammation horses need for long-term relief from osteoarthritis, while providing bioscaffolding that might support healthy tissue regeneration.

In a new study researchers have shown 2.5% injectable polyacrylamide hydrogel (iPAAG) injected into the joints causes a beneficial type of inflammation horses need for long-term relief from osteoarthritis, while providing bioscaffolding that might support healthy tissue regeneration.

The mild, microscopic-level inflammation lasts about 14 days after injection and appears to stimulate the immune system, which might help horses fight the degenerative disease process. The bioscaffolding, meanwhile, develops inside the synovial membrane (joint lining) as the tissue fully absorbs the drug-free gel, said Jason Lowe, MBA, BVSc, Cert EP, managing partner at Innovative Medical Solutions Vet, in Cambridge, New Zealand.

“In biology, there’s good inflammation and bad inflammation,” Lowe said. “Good inflammation is part of the body’s natural immune response. So, if we’re supporting the body’s natural immune response with products like this gel, we’re creating the environment for healing naturally.” This is in stark contrast to cortisone that artificially suppresses the immune response, he added.

While investigators on recent studies have shown that iPAAG injections seem to improve lameness in horses with osteoarthritis, experts still don’t understand exactly what is happening inside the joints on a microscopic level, Lowe said.

He and his fellow researchers injected 13 fetlock or central knee joints in 10 healthy Thoroughbreds with 2.5% synthetic cross-linked polyacrylamide gel at a dose of either 50 or 100 milligrams. These horses were 3 to 5 years old and had no signs of joint disease. For later comparison they aspirated synovial fluid from seven of the horses’ joints before injecting them.

The researchers examined each injected joint immediately after treatment and again either 14, 42, or 90 days later. During these exams the researchers aspirated synovial fluid for analysis. They euthanized four of the horses—two at Day 14 and two at Day 42—for more detailed tissue sample analyses, including microscopic examination. They also examined untreated opposite limbs in the euthanized horses.

All horses appeared normal during physical exams post-injection, with no lameness or obvious swelling, regardless of the dose. The researchers found no visible changes in the joints during dissection and no remaining free gel. They also found the synovial fluid cellular makeup was normal, except for a significant increase in macrophages, which are immune cells designed to “eat” foreign materials and debris, by Day 14.

In further analyses the researchers saw a microscopic inflammatory reaction, with swelling of protruding structures called the villi, filling with more macrophages. They also noticed more blood vessels in treated than untreated joints.

Shandong Peninsula Talent Technology Co., Ltd.

Professional manufacturer of PAM, provide customers with quality products and services

Contact Info

WhatsApp: 

Fax

+86-535-4288378

Address: 

Taiwan Industrial Park, Jianggezhuang Street, Muping District, Yantai City, Shandong Province, P.R.China


© Shandong HiFar Chem Co.,Ltd   SEO 

Business License

auto

Send Inquiry

contact

Provide you with quality products and services

Please contact us in time to get your exclusive offer!

Submit